Jacob Mandel

Jacob Mandel, M.D., is an Associate Professor in the Department of Neurology at Baylor College of Medicine and a member of the Dan L Duncan Comprehensive Cancer Center. He specializes in neuro-oncology, focusing on primary brain tumors, brain metastases, and neurologic complications of cancer. Dr. Mandel's roles include co-leader of the Glioma Working Group and co-moderator of the Brain Tumor Board at Baylor.

Education: MD from Rush Medical College (2008), BS from University of Illinois-Chicago (2004). Clinical training includes residency and internship at Ohio State University Medical Center, and a clinical fellowship at MD Anderson Cancer Center.

Research interests span neuro-oncology topics such as glioblastoma treatment strategies, venous thromboembolism in malignant brain tumors, and disparities in cancer care. His work has been published in journals like Neuro-Oncology, Journal of Neuro-Oncology, and Neurology.

Dr. Mandel is actively involved in clinical trials for primary brain tumors and contributes to education programs for neurology residents and hem/onc fellows. His research emphasizes translational insights into tumor biology and clinical outcomes.

Affiliations include Baylor Neurology Clinic at the McNair Campus in Houston, Texas. He maintains board certifications in Neurology and Neuro-Oncology.